 several randomized trials of ionic
and nonionic contrast agents have demonstrated no
difference in CIN.139
In summary, minimizing the volume of any type of
contrast agent is essential to reducing the risk of CIN,
and all nephrotoxic drugs should be stopped at least
48 hours before administration of contrast material.
Patients at increased risk for CIN should be hydrated
before and after EVAR. Normal saline at 1 mL/kg/h can
be administered for